XBiotech Inc (4XB.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 02:10PM CEST. Market open.
| Previous close | 7.60 |
| Open | 7.65 |
| Bid | 7.50 x 19600 |
| Ask | 7.85 x 18800 |
| Day's range | 7.65 - 7.65 |
| 52-week range | 2.94 - 9.20 |
| Volume | |
| Avg. volume | 96 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 08 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
Key Insights XBiotech's significant retail investors ownership suggests that the key decisions are influenced by...
GlobeNewswireXBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility. XBiotech has received City of Austin approval to begin excavation for site preparation and groundwork is expected to begin 1st quarter 2024. The new fou
- Simply Wall St.
Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.